07 August 2025 : Database Analysis
Trends and Efficacy in Clostridioides difficile Infection Management at a Polish Clinical Hospital
Jarosław Drobnik
ABDEG 1, Piotr Pobrotyn ADEFG 2*, Urszula Grata-Borkowska DF 1, Katarzyna Madziarska DE 3, Mateusz Baran ABCDEF 4
DOI: 10.12659/MSM.948254
Med Sci Monit 2025; 31:e948254
Table 2 Analysis of the treatment of CDI and the number of deaths by year of hospitalization at the UCHW in 2016–2018.
| Method of treatment (%) | 2016 | 2017 | 2018 | P |
|---|---|---|---|---|
| Metronidazol | 32 (41.6) | 29 (25.4) | 25 (21.7) | |
| Vancomycin | 14 (18.2) | 19 (16.7) | 31 (27.0) | |
| Metronidazole and vancomycin | 30 (39.0) | 53 (46.5) | 45 (39.1) | |
| Rifaximin or fidaxomicin and metronidazole and/or vancomycin | 1 (1.3) | 13 (11.4) | 14 (12.2) | |
| Death=Yes (%) | 20 (25.3) | 31 (26.3) | 29 (23.8) | 0.904 |